NCT01179217 2020-08-19A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemiaEmmaus Medical, Inc.Phase 3 Completed230 enrolled 19 charts 1 FDA
NCT02654652 2019-06-05Impact of Symbiotic Administration on Intestinal Function of Head and Neck Patients Surgically TreatedFederal University of Minas GeraisPhase NA Completed40 enrolled 7 charts